PharmacoEconomics

Accounting for Noncompliance in Pharmacoeconomic Evaluations
pp. 1185-1197(13)
Authors: Hughes D.A.; Bagust A.; Haycox A.; Walley T.

Incremental Cost Effectiveness of Prophylaxis for Cytomegalovirus Disease in Patients with AIDS
pp. 1199-1208(10)
Authors: Kempen J.H.; Frick K.D.; Jabs D.A.

Economic Evaluation of Collagenase-Containing Ointment and Hydrocolloid Dressing in the Treatment of Pressure Ulcers
pp. 1209-1216(8)
Authors: Müller E.; van Leen M.W.F.; Bergemann R.

Direct Costs of Schizophrenia in Italian Community Psychiatric Services
pp. 1217-1225(9)
Authors: Garattini L.; Rossi C.; Tediosi F.; Cornaggia C.; Covelli G.; Barbui C.; Parazzini F.

Paclitaxel: A Pharmacoeconomic Review of its Use in the Treatment of Ovarian Cancer
pp. 1227-1259(33)
Authors: Young M.; Plosker G.L.